Abstract

Hyperspectral imaging (HSI) is a non-invasive optical imaging modality that shows the potential to aid pathologists in breast cancer diagnoses cases. In this study, breast cancer tissues from different patients were imaged by a hyperspectral system to detect spectral differences between normal and breast cancer tissues. Tissue samples mounted on slides were identified from 10 different patients. Samples from each patient included both normal and ductal carcinoma tissue, both stained with hematoxylin and eosin stain and unstained. Slides were imaged using a snapshot HSI system, and the spectral reflectance differences were evaluated. Analysis of the spectral reflectance values indicated that wavelengths near 550 nm showed the best differentiation between tissue types. This information was used to train image processing algorithms using supervised and unsupervised data. The K-means method was applied to the hyperspectral data cubes, and successfully detected spectral tissue differences with sensitivity of 85.45%, and specificity of 94.64% with true negative rate of 95.8%, and false positive rate of 4.2%. These results were verified by ground-truth marking of the tissue samples by a pathologist. In the hyperspectral image analysis, the image processing algorithm, K-means, shows the greatest potential for building a semi-automated system that could identify and sort between normal and ductal carcinoma in situ tissues.

Highlights

  • Breast cancer is one of the highest causes of cancer deaths among American women [1,2,3,4]

  • The algorithms are used to learn the about the nature of the hyperspectral data to understand the spectral reflectance value and how it can be used to differentiate between different regions in the tissue samples

  • We analyzed the manually picked regions of the hyperspectral images, plotted the spectral reflectance spectrum to compare between the tissues

Read more

Summary

Introduction

Breast cancer is one of the highest causes of cancer deaths among American women [1,2,3,4]. According to the U.S Breast Cancer Organization, statistics show that about one in eight U.S women will develop invasive breast cancer over their lifetime [1,2,3]. In 2016, about 246,660 new cases of invasive breast cancer were diagnosed in women. The role of the pathologist is undeniably important for cancer diagnosis [4, 5]. As the number of breast cancer cases increases, the burden of pathological cases becomes onerous. Any new technology that can expedite breast cancer detection and diagnosis using biopsy slides, making the process easier and more efficient, is warranted

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call